Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549)

BACKGROUND: Ciclesonide is a novel inhaled corticosteroid for the treatment of airway inflammation. In this study we investigated uptake and in vitro metabolism of ciclesonide in human alveolar type II epithelial cells (A549). Ciclesonide uptake was compared with fluticasone propionate, an inhaled c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nonaka, Takashi, Nave, Rüdiger, McCracken, Nigel, Kawashimo, Atsuko, Katsuura, Yasuhiro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central|1 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048954/
https://www.ncbi.nlm.nih.gov/pubmed/17900334
http://dx.doi.org/10.1186/1471-2210-7-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048954/
https://www.ncbi.nlm.nih.gov/pubmed/17900334
http://dx.doi.org/10.1186/1471-2210-7-12

Ejemplares similares